|

ITI-1284 Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Pipeline

Phase 2: 2Phase 3: 1

Top Sponsors

  • Intra-Cellular Therapies, Inc.3

Indications

  • Alzheimer's Disease2
  • Agitation Associated With Alzheimer's Dementia1
  • Psychosis Associated With Alzheimer's Disease1
  • Generalized Anxiety Disorder1
  • Psychotic Disorders1

Anaheim, California2 trials

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

Advanced Research Center, Inc

Phase 2
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Advanced Research Center, Inc

Phase 2

Los Angeles, California1 trial

A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)

CalNeuro Research

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.